LivaNova PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LivaNova PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 145.48K shares, a 38.42% decline from fiscal 2024.
- LivaNova PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 236.25K shares, a 1.40% increase from fiscal 2023.
- LivaNova PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 232.98K shares, a 150.00% increase from fiscal 2022.
- LivaNova PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 93.19K shares, a 78.03% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 145.48K shares 10-K · filed 2026-02-25 | |
| 2024-12-31 | 236.25K shares 10-K · filed 2025-02-25 | |
| 2023-12-31 | 232.98K shares 10-K · filed 2024-02-29 | |
| 2022-12-31 | 93.19K shares 10-K · filed 2023-02-27 | |
| 2021-12-31 | 424.12K shares 10-K · filed 2022-03-01 | |
| 2020-12-31 | 58.77K shares 10-K · filed 2021-03-01 | |
| 2019-12-31 | 121.53K shares 10-K · filed 2020-03-02 | |
| 2018-12-31 | 599.60K shares 10-K · filed 2019-03-18 | |
| 2017-12-31 | 345.51K shares 10-K · filed 2018-02-28 | |
| 2016-12-31 | 256.29K shares 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |